Ningbo MedicalSystem Biotechnology Co Ltd (300439) — Capital Reinvestment Ratio

Latest as of September 2025: 0.24x

Ningbo MedicalSystem Biotechnology Co Ltd (300439) has a Capital Reinvestment Ratio of 0.24x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥48.96 Million) in capital expenditures (CN¥11.70 Million). Check 300439 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.24x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥48.96 Million
CNY

Capital Expenditures

CN¥11.70 Million
CNY

Data as of

Sep 2025
Most recent filing

Ningbo MedicalSystem Biotechnology Co Ltd Capital Reinvestment Ratio (2011–2024)

This chart tracks Ningbo MedicalSystem Biotechnology Co Ltd's Capital Reinvestment Ratio across 13 annual periods. For the full cash flow conversion analysis, see 300439 cash flow conversion.

Annual Capital Reinvestment Ratio for Ningbo MedicalSystem Biotechnology Co Ltd (2011–2024)

Year-by-year Capital Reinvestment Ratio for Ningbo MedicalSystem Biotechnology Co Ltd from 2011 to 2024. See Ningbo MedicalSystem Biotechnology Co Lt (300439) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2024 1.06x CN¥397.81 Million CN¥420.54 Million ▲ +138.9%
2023 0.44x CN¥633.53 Million CN¥280.37 Million ▼ -17.6%
2022 0.54x CN¥564.67 Million CN¥303.13 Million ▲ +37.1%
2021 0.39x CN¥515.48 Million CN¥201.82 Million ▼ -6.9%
2020 0.42x CN¥912.07 Million CN¥383.43 Million ▼ -30.4%
2019 0.60x CN¥601.17 Million CN¥363.20 Million ▼ -43.3%
2018 1.07x CN¥418.80 Million CN¥446.22 Million ▼ -99.1%
2016 119.24x CN¥2.45 Million CN¥292.59 Million ▲ +22844.1%
2015 0.52x CN¥177.55 Million CN¥92.27 Million ▼ -17.8%
2014 0.63x CN¥116.51 Million CN¥73.63 Million ▼ -12.9%
2013 0.73x CN¥100.06 Million CN¥72.61 Million ▼ -40.0%
2012 1.21x CN¥46.78 Million CN¥56.60 Million ▲ +96.3%
2011 0.62x CN¥49.82 Million CN¥30.71 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow